-
In this issue: Does erythropoietin worsen cancer death rates? Most hypothyroid patients can be replaced with levothyroxine alone without additional T3. Does aggressive control in type 2 diabetes save lives?
-
The Women's Health Initiative investigators reported health outcomes at 3 years after the estrogen-progestin arm of the clinical trial was canceled.
-
In a previous Clinical Alert, the risk of uterine rupture in patients attempting vaginal birth after cesarean sections (VBACs) was addressed when it appeared that there was a distinct downturn in the amount of VBACs being done in the USA.
-
One hundred and twenty subjects with symptoms of idiopathic detrusor overactivity (OAB) were recruited to evaluate the efficacy of reflexology compared to nonspecific foot massage.
-
Stop smoking drug Chantix rates stronger warning from FDA; Type 2 diabetes surgery on the way?; Vytorin study inconclusive; Influenza A virus found resistant to Tamiflu; FDA actions.
-
Most cases of thrombocytopenia seen are expected. Patients are known to have hematological disease or are receiving chemotherapy. At times, however, the physician is confronted with an unexpected laboratory finding in an asymptomatic patient, or with a patient who is bleeding. The challenge, as usual, is to determine the need for acute treatment and the appropriate disposition.
-
-
-
Stop smoking drug Chantix rates stronger warning from FDA; Type 2 diabetes surgery on the way?; Vytorin study inconclusive; Influenza A virus found resistant to Tamiflu; FDA actions.
-
12-lead ECG and lead II rhythm strip obtained from a 90-year-old woman with acute dyspnea and diaphoresis.